BIOCOPY
LIVE

Serial Number

79298902

Owner

BioCopy GmbH

Attorney

Joyce von Natzmer

Filing Date

Jul 17, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BIOCOPY Trademark

Serial Number: 79298902 • Registration: 6495691

BIOCOPY is a trademark filed by BioCopy GmbH on July 17, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BioCopy GmbH

Elzstrasse 27

Entity Type: 27

Trademark Details

Filing Date

July 17, 2020

Registration Date

September 28, 2021

Published for Opposition

July 13, 2021

Goods & Services

Apparatus for scientific research and laboratories, namely, reflectometers; recorded content in the nature of software for analyzing biomolecule sequences; information technology and audio-visual, multimedia and photographic devices, namely, molecule detection systems; measuring, detecting and monitoring instruments, indicators and controllers; DNA chips; DNA microarray; microarray slides being laboratory equipment; microscope slides being laboratory equipment; biochips for research or scientific purposes; bio-sensors being sensors for use in biomolecular measurement; Downloadable software for use in the field of bioinformatics

Chemical preparations for use in DNA analysis, namely, preparations for diagnosing bacterial or viral diseases, metabolic disorders or cancer for medical purposes; reagents for use in analysis, namely, veterinary diagnostic reagents; reagents for analytical purposes, namely, reagents for medical purposes; chemical, diagnostic reagents for analytical and veterinary purposes; reagents for microbiological analysis, for medical purposes; reagents for microbiological analysis, for veterinary purposes; reagents for use in analysis of biomolecule samples, for medical purposes; reagents for use with analyzers, for veterinary purposes; reagents for use with analyzers, for medical purposes; vaccines; diagnostic biomarker reagents for medical purposes

Biological inoculants, other than for medical use; inoculants, other than for medical or veterinary use; proteins for use in recombinant DNA technology, other than for medical use; proteins for industrial use; proteins for use in science; proteins for binding antibodies, other than for medical use; proteins for detecting antibodies, other than for medical use; regulatory proteins for industrial use; regulatory proteins for scientific use

Medical consultancy and information services relating to pharmaceutical products; medical consultancy and information services relating to biopharmaceutical products; medical consultancy and information services relating to medical products; DNA screening for medical purposes; Medical analysis services, namely, RNA and DNA analysis for cancer diagnosis and prognosis; Medical analysis services, namely, laboratory analysis services relating to the treatment of persons; Medical analysis services, namely, laboratory analysis services relating to the treatment of animals; medical analysis services relating to the treatment of persons; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic services; medical and health assessment services relating to DNA, genetics and genetic testing; medical advisory, consultancy and information services relating to the development and detection of vaccines

Scientific and technological services, namely, scientific research and analysis in the field of biomolecule copying and analysis; Product testing and quality control for others; Authentication, namely, Providing user authentication services using single sign-on technology for online software applications; provision of information and data relating to medical and veterinary research and development; providing information about industrial analysis and research services in the field of biomolecule copying; biochemical analysis; biochemical research and analysis; biological analysis; biological research and analysis; blood analysis services for scientific research purposes; analytical laboratory service for medical purposes; Product development for other, namely, development of coatings for non-metals; research and development of vaccines and medicines; research and development services in the field of antibody technology; research and development services relating to vaccines; research and development services in the field of antibodies; information technology consulting services for the pharmaceutical and healthcare industries; laboratory services relating to the production of monoclonal antibodies; scientific analysis, namely, biomolecule analysis services for scientific research purposes; scientific research and analysis in the field of biomolecule copying

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Mar 21, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 4, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 16, 2022 FICS
FINAL DISPOSITION PROCESSED
Mar 16, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 28, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 28, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Jul 19, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 13, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 13, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 30, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 30, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 23, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 4, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 3, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 3, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 3, 2021 TROA
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 5, 2021 ADCH
REFUSAL PROCESSED BY IB
Jan 4, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 12, 2020 RFCS
REFUSAL PROCESSED BY MPU
Dec 12, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Dec 8, 2020 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 5, 2020 RFCR
NON-FINAL ACTION WRITTEN
Dec 4, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 4, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 4, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 3, 2020 REPR